RNU6-786P

Across TCGA pan-cancer cohorts, RNU6-786P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-786P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RNU6-786P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-786P expression acts as an unfavorable survival marker, although some lineages such as BLCA and COAD show a favorable association.

UVM, CHOL, and UCS are the cancer types where RNU6-786P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.136	0.919	<.001	90	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	72	view →
UCS	OS	Tertile	All	0.255	0.703	.002	72	view →
UCEC	DFS	Tertile	IV	0.295	0.736	.008	54	view →
LUSC	DFS	Tertile	II,III,IV	0.226	0.403	.012	48	view →
MESO	DFS	Tertile	All	0.124	0.483	.016	27	view →
BLCA	DFS	Tertile	IV	1.000	0.279	.007	18	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	9	view →
COAD	DFS	Tertile	All	0.772	0.513	.037	9	view →
PCPG	DFS	Tertile	All	0.328	0.885	.001	9	view →
STAD	DFS	Quartile	All	0.276	0.422	.029	8	view →
BRCA	OS	Tertile	IV	0.274	0.647	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-786P–UVM (OS)

Open the UVM breakdown →